๐ Product Overview Table
| ๐ Specification | ๐งพ Details |
|---|---|
| ๐ Active Ingredient | Letrozole 2.5 mg |
| ๐ญ Manufacturer | Cipla Limited |
| ๐ Dosage Form | Oral Tablet |
| ๐ฆ Packaging | 10 Tablets in 1 Strip |
| ๐ฉบ Indication | Hormone receptor-positive breast cancer in postmenopausal women |
| ๐บ๐ธ US Brand Equivalent | Femara |
| โฑ๏ธ Delivery Time | 6 to 15 business days |
๐งฌ Introduction โ What is Fempro 2.5mg?
Fempro 2.5mg by Cipla Limited is a generic version of Letrozole, an aromatase inhibitor primarily prescribed for postmenopausal women with hormone receptor-positive breast cancer. It works by lowering estrogen levels in the body, which helps slow or reverse the growth of hormone-sensitive tumors.
Letrozole is also commonly used as part of fertility treatment protocols due to its ability to stimulate ovulation. Fempro is a trusted, affordable Indian alternative to the global brand Femara, making it accessible for patients worldwide.
๐ฅ Educational Video โ Letrozole Mechanism and Uses
๐บ “Letrozole (Fempro) Explained: Breast Cancer & Fertility Uses“
๐ฌ Video Placeholder โ Watch how Fempro inhibits aromatase enzyme and its key indications.
โ ๏ธ Not suitable for premenopausal women with breast cancer unless directed by a physician.
๐ฌ Pharmacology & Mechanism of Action
| โ๏ธ Component | ๐ Mode of Action |
|---|---|
| Letrozole | Inhibits aromatase enzyme to block estrogen synthesis |
- Reduces estrogen levels
- Slows progression of estrogen-sensitive tumors
- Stimulates ovulation by releasing FSH in fertility treatment
๐ Dosage & Administration
| ๐ Condition | ๐ Recommended Dose |
|---|---|
| Breast cancer (postmenopausal) | 2.5 mg once daily |
| Ovulation induction (off-label use) | 2.5โ5 mg daily for 5 days |
Always follow a doctorโs instructions. May be taken with or without food.
โ ๏ธ Side Effects & Warnings
| ๐ฅ Common Side Effects | โ Severe Reactions |
|---|---|
| Hot flashes, dizziness | Bone fractures, chest pain, allergic rash |
| Fatigue, nausea | Vision problems, severe abdominal pain |
| Headaches, joint pain | Liver toxicity (rare), shortness of breath |
Avoid use in patients with severe liver dysfunction or osteoporosis unless supervised.
๐ง Storage Guidelines
- Store at temperatures below 25ยฐC (77ยฐF)
- Protect from moisture and direct sunlight
- Keep out of reach of children
๐ Global Buying & Import Details
| ๐ Country | ๐ Import Rule | ๐ Prescription Required |
|---|---|---|
| ๐บ๐ธ USA | FDA personal importation policy applies | โ Required |
| ๐ฌ๐ง UK | Allowed via MHRA import clause | โ Required |
| ๐ฆ๐บ Australia | Permitted under TGA personal import scheme | โ Required |
Estimated Delivery Time: 6โ15 business days from India
๐ Related Hormonal Therapy Options (Internal Links)
| ๐ Product | ๐ญ Manufacturer | ๐ Short Description |
|---|---|---|
| Altraz 1mg | Alkem Laboratories Ltd | Aromatase inhibitor used for postmenopausal breast cancer |
| Armotraz | Cipla Limited | Alternative to Femara with same Letrozole content |
| Duphaston 10mg | Abbott India Pvt. Ltd. | Synthetic progesterone for hormone-related gynecological issues |
| Evadiol 2mg | Intas Pharmaceuticals | Oral estrogen tablet for menopause and HRT |
| Progynova 2mg | Zydus Healthcare | Estradiol replacement for hormonal support |
๐ Trusted References
- Drugs.com โ Letrozole
- NHS Breast Cancer Guidelines
- Cipla Official Website
- PubMed โ Letrozole Clinical Trials
๐ฉบ Doctorโs Perspective โ Dr. Neha Bansal, MD (Oncology)
“Fempro 2.5 mg provides an affordable, evidence-based approach to managing hormone-dependent breast cancer and is also gaining traction in assisted reproduction. It is a vital component of treatment for many women globally.”
โ ๏ธ Disclaimer
This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before beginning treatment with Letrozole or any hormone therapy.




